Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
1.530
-0.160 (-9.47%)
At close: Nov 1, 2024, 4:00 PM
1.560
+0.030 (1.96%)
After-hours: Nov 1, 2024, 5:45 PM EDT
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $313.56 million as of November 1, 2024. Its market cap has increased by 135.05% in one year.
Market Cap
313.56M
Enterprise Value
199.12M
1-Year Change
135.05%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has decreased from $690.43M to $313.56M, a decrease of -54.58%. That is a compound annual growth rate of -17.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 1, 2024 | 313.60M | -5.23% |
| Dec 29, 2023 | 330.90M | 134.51% |
| Dec 30, 2022 | 141.10M | -68.52% |
| Dec 31, 2021 | 448.20M | -55.28% |
| Dec 31, 2020 | 1.00B | 45.16% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jasper Therapeutics | 321.29M |
| Jin Medical International | 320.92M |
| Aldeyra Therapeutics | 318.50M |
| Eledon Pharmaceuticals | 316.62M |
| Spok Holdings | 313.89M |
| OraSure Technologies | 310.95M |
| Rezolute | 307.60M |
| Aurora Cannabis | 305.13M |